Onkologie. 2010:4(4):230-232

Nonmelanoma Skin Cancer

Barbora Divišová, Petra Cetkovská, Karel Pizinger
Dermatovenerologická klinika LF UK a FN Plzeň

Nonmelanoma skin cancer (NMSC), encompassing basal cell carcinoma (BCC), squamous cell carcinoma (SCC), is the most frequent cancer

in fair-skinned populations, particularly frequent in coun tries with high sun exposure and in immu nosuppressed patients. The incidence

of NMSC has increased dramatically worldwide. Although BCC and SCC possess many similar features, there are fundamentals biological

differences. Actinic keratosis (AK) is thought to be part of a continuum along the path to the development of SCC. Most of the time the

diagnosis of NMSC is based on clinical presentation, however histological findings play in some cases main role. Whereas surgery remains

the gold-standard therapy for NMSC, noninvasive methods have shown promising results to treat superficial BCC, AK and subclinical lesions

on large body areas.

Keywords: skin cancer, basal cell carcinoma, squamous cell carcinoma, actinic keratosis, patched gene

Published: October 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Divišová B, Cetkovská P, Pizinger K. Nonmelanoma Skin Cancer. Onkologie. 2010;4(4):230-232.
Download citation

References

  1. Pfister H. HPV und Neoplasien der Haut. Hautarzt 2008; 59: 26-30. Go to original source... Go to PubMed...
  2. Leiter U, Garbe C. Epidemiology of melanoma and nonmelanoma skin cancor - the role of sunlight. Adv Exp Med Biol 2008; 624: 89-103. Go to original source... Go to PubMed...
  3. Einspahr JG, Alberts DS, Warneke JA, Bozzo P, Basye J, Grogan TM, et al. Relationshiwp of p53 mutations to epidermal cell proliferation and apoptosis in human UV-induced skin carcinogenesis. Neoplasia 1999; 1(5): 468-475. Go to original source... Go to PubMed...
  4. Tsao H. Genetics of nonmelanoma skin cancer. Arch Dermatol 2001; 137: 1486-1492. Go to original source... Go to PubMed...
  5. Gailani MR, Stahle-Backdahl M, Leffell DJ, et al. The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nat Genet 1996; 14: 78-88. Go to original source... Go to PubMed...
  6. Dlugosz A, Merlino G, Yuspa SH. Progress in cutaneous cancer research J Invest Dermatol 2002; Symp Proc 7: 17-26. Go to original source... Go to PubMed...
  7. Mortier L, Marchetti P, Delaporte E, et al. Progression of actinic keratosis to squamous cell carcinoma of the skin correlates with deletion of the 9p21 region encoding the p16 (INK4a) tumor suppressor. Cancer Lett 2002; 176: 205-214. Go to original source... Go to PubMed...
  8. Williams JA, Guicherit OM, Zaharian BI, et al. Identification of a small molekule inhibitor of the hedgehog signaling pathway: effects on basal cell carcinoma-like lesions. Proc. Natl. Acad. Sci USA 2003; 100: 4616-4621. Go to original source... Go to PubMed...
  9. Štork J, et al. Dermatovenerologie. Karolinum: Galén, 2008: 388-392.
  10. Miller SJ, Moresi JM. Actinic keratosis, basal cell carcinoma and squamous cell carcinoma. In: Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology. London: Mosby, 2003: 1677-1696.
  11. Stockfleth E, Kerl H. Guidelines for the management od actinic keratoses. Eu J Dermatol 2006; 16(6): 599-606.
  12. Weedon D. Tumors in the epidermis. In: Weedon D, eds. Skin patology. Churchill Livingstone, 3. vydání, 2010: 667-708. Go to original source...
  13. Cockerell CJ. Histopathology of incipient intraepidermal squamous cell carcinoma (actinic keratosis). J Am Acad Dermatol 2000; 42(S): 11-17. Go to original source... Go to PubMed...
  14. Lysa B, Tartler U, Wolf R, et al. Gene expression in actinic keratoses: pharmacological modulation by Imiquimod. Br J Dermatol 2004; 151(6): 1150-1159. Go to original source... Go to PubMed...




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.